Medistim ASA (LON: 0OCD)
London
· Delayed Price · Currency is GBP · Price in NOK 148.50
-1.00 (-0.67%)
Jan 27, 2025, 8:35 AM BST
Medistim ASA Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 24, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 209 | 303 | 355 | 561 | 389 | 300 | Upgrade
|
| Market Cap Growth | -22.51% | -14.73% | -36.70% | 44.30% | 29.63% | 156.70% | Upgrade
|
| Enterprise Value | 200 | 293 | 346 | 556 | 382 | 297 | Upgrade
|
| Last Close Price | 10.59 | 16.15 | 18.68 | 29.15 | 17.87 | 14.27 | Upgrade
|
| PE Ratio | 28.98 | 37.68 | 36.99 | 73.63 | 65.58 | 49.67 | Upgrade
|
| PS Ratio | 6.03 | 7.51 | 8.67 | 16.02 | 12.77 | 9.78 | Upgrade
|
| PB Ratio | 8.07 | 9.83 | 11.47 | 21.87 | 17.72 | 14.74 | Upgrade
|
| P/TBV Ratio | 9.51 | 11.10 | 12.71 | 24.26 | 20.30 | 17.58 | Upgrade
|
| P/FCF Ratio | 32.58 | 40.42 | 40.45 | 55.79 | 68.24 | 52.36 | Upgrade
|
| P/OCF Ratio | 28.00 | 34.56 | 37.15 | 52.55 | 61.38 | 43.45 | Upgrade
|
| EV/Sales Ratio | 5.19 | 7.27 | 8.45 | 15.87 | 12.56 | 9.67 | Upgrade
|
| EV/EBITDA Ratio | 18.73 | 25.83 | 26.11 | 52.09 | 42.60 | 33.81 | Upgrade
|
| EV/EBIT Ratio | 22.04 | 28.83 | 29.10 | 59.73 | 46.87 | 38.46 | Upgrade
|
| EV/FCF Ratio | 28.16 | 39.15 | 39.43 | 55.26 | 67.11 | 51.77 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.04 | 0.05 | 0.08 | 0.15 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.05 | 0.11 | 0.10 | 0.18 | 0.35 | 0.34 | Upgrade
|
| Debt / FCF Ratio | 0.07 | 0.18 | 0.16 | 0.20 | 0.59 | 0.55 | Upgrade
|
| Asset Turnover | 1.12 | 1.05 | 1.10 | 1.12 | 1.04 | 1.18 | Upgrade
|
| Inventory Turnover | 0.75 | 0.86 | 1.01 | 0.92 | 0.76 | 1.04 | Upgrade
|
| Quick Ratio | 2.75 | 2.53 | 2.64 | 2.62 | 2.23 | 1.91 | Upgrade
|
| Current Ratio | 4.82 | 4.15 | 3.87 | 3.95 | 4.13 | 3.20 | Upgrade
|
| Return on Equity (ROE) | 25.95% | 27.12% | 33.83% | 32.30% | 28.11% | 31.70% | Upgrade
|
| Return on Assets (ROA) | 16.50% | 16.62% | 19.93% | 18.52% | 17.50% | 18.53% | Upgrade
|
| Return on Capital (ROIC) | 20.05% | 20.53% | 24.69% | 22.15% | 20.97% | 22.88% | Upgrade
|
| Return on Capital Employed (ROCE) | 30.83% | 31.95% | 36.90% | 34.08% | 33.35% | 33.92% | Upgrade
|
| Earnings Yield | 3.45% | 2.65% | 2.70% | 1.36% | 1.52% | 2.01% | Upgrade
|
| FCF Yield | 3.41% | 2.47% | 2.47% | 1.79% | 1.47% | 1.91% | Upgrade
|
| Dividend Yield | 2.57% | 2.16% | 2.03% | 1.08% | 1.43% | 1.66% | Upgrade
|
| Payout Ratio | 80.85% | 79.15% | 60.01% | 60.11% | 72.13% | 58.21% | Upgrade
|
| Buyback Yield / Dilution | -0.17% | -0.10% | -0.15% | -0.07% | -0.13% | 0.01% | Upgrade
|
| Total Shareholder Return | -0.17% | 2.05% | 1.88% | 1.01% | 1.30% | 1.66% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.